|
Answers: 2010 Series - April 6, 2010
|
Lecture 39 of 52 NEXT»
|
To see views enlarged, click on the individual pictures...
Photos courtesy of: Bita Esmaeli, M.D. / M.D. Anderson Cancer Center
Used with permission. Not to be reproduced.
| A 57-year-female presented with painless right lacrimal fossa fullness and diplopia. MRI and histology of a touch prep and permanent section of an incisional biopsy specimen are shown. |
| 1. |
This represents: |
|
e -- the most common primary orbital malignancy in adults
This patient had MALT orbital lymphoma. The MRI shows a well circumscribed orbital mass that molds to orbital structures without bony destruction. The touch prep identifies abnormal appearing lymphocytes, and the permanent section slide confirms lymphoma showing a monotonous population of lymphocytes. Orbital lymphoma is the most common primary orbital malignancy in adults, however it is a lymphoproliferative (and not epithelial) tumor.
|
| 2. |
The next step in the care of this patient should be: |
|
e -- systemic evaluation of involvement of other sites
All ocular adnexal and orbital lymphoproliferative lesions warrant systemic evaluation to investigate other potential anatomic sites involved prior to treatment considerations. Work-up may include head and neck imaging through CT or MRI, neck ultrasound, CT of the chest/abdomen/pelvis, whole body PET CT, bone marrow biopsy, and when warranted upper endoscopy.
|
| 3. |
If the patient’s disease is localized to the orbit, treatment may be: |
|
d -- radiotherapy
Treatment of orbital lymphoma may include radiotherapy, chemotherapy, or radioimmunotherapy (Rituximab) or a combination thereof.
|
|